| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Oct―23 |
Rheumatoid Arthritis Development following COVID-19 Infection: Eighth Case Described |
Jozélio Freire de Carvalho, Felipe Freire da Silva |
| 2 |
[GO] |
2024―Aug―07 |
COVID-19-Induced Rheumatoid Arthritis: Case Series and Systematic Review of the Literature |
Selma Bouden, Hiba Ben Ayed, Leila Rouached, Aicha Ben Tekaya, Ines Mahmoud, Raoudha Tekaya, et al. (+2) Olfa Saidane, Leila Abdelmoula |
| 3 |
[GO] |
2024―May―11 |
Transient Aortitis after COVID-19 mRNA Vaccination |
Hiroaki Nishioka, Yuuki Okumura |
| 4 |
[GO] |
2024―May―11 |
New-Onset MDA-5 Dermatomyositis in a Patient Following COVID-19 Vaccination: A Case Report |
Eleana Bolla, George E. Fragoulis, Alexios Iliopoulos |
| 5 |
[GO] |
2024―May―11 |
Safety of COVID-19 Vaccine in Patients with Rheumatic and Musculoskeletal Diseases |
Ali Abdulrahman Younis, Asal Adnan Ridha, Yasameen Abbas Humadi, Nizar Abdulateef Jassim, Nabaa Ihsan Awadh, Avin Maroof, et al. (+10) Ali Mohammed Hussein Alqazzaz, Faiq I. Gorial, Taha Ahmed Qaradaghi, Zahraa Salam Abdulzahra, Zainab A. Mahmood, Noor Talal Yaseen, Duaa Nidhal AlIdrecy, Israa Talib Hakman, Saja Jabbar Tarfah, Adil Saudi Khudhair |
| 6 |
[GO] |
2024―Feb―17 |
Comparison of Risk Factors During First and Second Wave of COVID-19 in Patients with Autoimmune Rheumatic Diseases (AIRD): Results from KRACC Subset |
Vikramraj Jain, Vineeta Shobha, Sharath Kumar, Ramya Janardana, Sumithra Selvam |
| 7 |
[GO] |
2024―Feb―17 |
SARS-CoV-2 Infection-Induced Necrotising Sarcoid Granulomatosis |
Aysu Sinem Koc, Neslihan Fener, Senol Kobak |
| 8 |
[GO] |
2023―Sep―05 |
Prevalence & Impact of COVID-19 in Systemic Sclerosis Patients and Assessment of the Demographic & Clinical Features in Cases Associated with Worse Prognosis: Results of a Single Centre Registry |
Hadi Poormoghim, Fatemeh GaffariRad, Shahrzad Rahmani, Negin Mohtasham, Simin Almasi, Ali Sobhani, et al. (+4) Maryam Salimi-Beni, Elham Andalib, Parsa Amiri Naeini, Arash Jalali |
| 9 |
[GO] |
2023―Sep―05 |
Pulmonary-Renal Syndrome During COVID-19 Pandemic Revealed a Rare Case of Anti-GBM Disease |
Aglaia Chalkia, Christos Koutsianas, Emelina Stampolliou, Panagiota Giannou, Harikleia Gakiopoulou, Dimitrios Vassilopoulos, Dimitrios Petras |
| 10 |
[GO] |
2023―May―23 |
Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine |
Olga K. Katsouli, Vasileios G. Lainis, Gerasimos G. Kapellos, Panayiotis G. Vlachoyiannopoulos |
| 11 |
[GO] |
2023―Jan―21 |
The Anxiety and Depression in Rheumatoid Arthritis Patients Treating with Disease-Modifying Anti-Rheumatic Drugs during the COVID-19 Pandemic |
Gökhan Sargın, Huseyin Baygin, Taskin Senturk |
| 12 |
[GO] |
2023―Jan―21 |
Anti-Interleukins for Severe Coronavirus Disease-2019: Hype or Hope? |
Athina Dimosiari, Dimitrios Patoulias, Demosthenes Makris |
| 13 |
[GO] |
2022―Nov―25 |
Prevalence of COVID-19 in Different Types of Vascular Collagen Diseases and its Relationship with Drugs Used in these Patients |
Simin Almasi, Elahe Mirzazade, Dorsa Barzi, Babak Eshrati |
| 14 |
[GO] |
2022―Sep―06 |
Hyperinflammation due to COVID-19 and the Targeted Use of Interleukin-1 Inhibitors |
Armen Yuri Gasparyan, George D. Kitas |
| 15 |
[GO] |
2022―Sep―06 |
Canakinumab might be Protective against Severe COVID-19 for Patients with Autoinflammatory Disorders |
Arif Alkan, Serdal Ugurlu |
| 16 |
[GO] |
2022―Sep―06 |
The Impact of Colchicine on COVID-19 patients: A Clinical Trial Study |
Farhad Salehzadeh, Farhad Pourfarzi, Sobhan Ataei |
| 17 |
[GO] |
2022―Apr―19 |
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients |
Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari, Alexandros A. Drosos |
| 18 |
[GO] |
2022―Jan―15 |
Assessment of Evidence for COVID-19 and Rheumatic Diseases: Brief Considerations about Immunity and Pathophysiology |
Zohreh Jadali |
| 19 |
[GO] |
2021―Oct―30 |
COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers |
Athanasios-Dimitrios Bakasis, Haralampos M. Moutsopoulos |
| 20 |
[GO] |
2021―Oct―30 |
Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19? |
Athanasios Sachinidis, Alexandros Garyfallos |
| 21 |
[GO] |
2021―Jan―27 |
Changes in Medical Education during the COVID-19 Pandemic |
Ilke Coskun Benlidayi |
| 22 |
[GO] |
2021―Jan―27 |
Vaccination Against SARS-CoV-2 in Immunosuppressed Patients with Rheumatic Diseases: Position Statement of the Greek Rheumatology Society |
|
| 23 |
[GO] |
2020―Nov―10 |
Monitoring Information Flow on Coronavirus Disease 2019 (COVID-19) |
Armen Yuri Gasparyan, Olena Zimba, Durga Prasanna Misra |
| 24 |
[GO] |
2020―Nov―10 |
Kawasaki Disease and COVID-19 |
Athanasios Gkoutzourelas, Dimitrios P. Bogdanos, Lazaros I. Sakkas |
| 25 |
[GO] |
2020―Nov―10 |
Mental Health and Psychological Wellbeing in Rheumatoid Arthritis during COVID-19 - Can Physical Activity Help? |
Jet J.C.S. Veldhuijzen van Zanten, Sally A.M. Fenton, Sophia Brady, George S. Metsios, Joan L. Duda, George D. Kitas |
| 26 |
[GO] |
2020―Nov―10 |
Practical Issues in Managing Systemic Inflammatory Disorders During the COVID-19 Pandemic |
Theodoros Dimitroulas, George Bertsias |
| 27 |
[GO] |
2020―Nov―10 |
Rheumatoid Arthritis in the Era of COVID-19 Pandemic |
Ahmed M. Abbas, Asmaa AbouBakr |
| 28 |
[GO] |
2020―Nov―10 |
Nocebo-Prone Behaviour in Patients with Autoimmune Rheumatic Diseases during the COVID-19 Pandemic |
George E. Fragoulis, Gerasimos Evangelatos, Aikaterini Arida, Vasiliki-Kalliopi Bournia, Kalliopi Fragiadaki, Anastasios Karamanakos, et al. (+7) Evrydiki Kravvariti, Katerina Laskari, Stylianos Panopoulos, Maria Pappa, Dimos D. Mitsikostas, Maria G. Tektonidou, Petros P. Sfikakis |
| 29 |
[GO] |
2020―Nov―10 |
Management of Patients with Inflammatory Diseases during the COVID-19 Pandemic |
Theofanis Apostolou, Ioannis E. Koutroubakis, Spilios Manolakopoulos, Gerasimos Mantzaris, Dimitrios Rigopoulos, Konstantinos Triantafyllou, Dimitrios Vassilopoulos |
| 30 |
[GO] |
2020―Nov―10 |
Potential Role of Anti-Complement Agents in the Treatment of COVID-19-Related ARDS |
Christina Spanopoulou, Dimitrios Kassimos, Dimitrios Cassimos |
| 31 |
[GO] |
2020―Nov―10 |
COVID-19: An Archetype Innate Immunity Reaction and Modes of Treatment |
Periklis Vounotrypidis |
| 32 |
[GO] |
2020―Nov―10 |
Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of COVID-19: An Online Survey |
Nizar Abdulateef Jassim, Dina Yasiry, Yasameen Abbass Hummadi |
| 33 |
[GO] |
2020―Nov―10 |
The Rheumatologist’s Role in the Battle Against COVID-19: Insights from the Front Line and Challenges for the Future |
Christos Koutsianas, Katerina Chatzidionysiou |
| 34 |
[GO] |
2020―Nov―10 |
Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence? |
Eleftherios Pelechas, Vassiliki Drossou, Paraskevi V. Voulgari, Alexandros A. Drosos |
| 35 |
[GO] |
2020―May―09 |
When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients? |
Dimitrios P. Bogdanos, Zoi Daniil, Epaminondas Zakynthinos, Konstantinos Gourgoulianis, Lazaros I. Sakkas |
